| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10409238309102799 |
| P698 | PubMed publication ID | 6319080 |
| P2093 | author name string | Liu LF | |
| P433 | issue | 1 | |
| P304 | page(s) | 1-24 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | CRC critical reviews in biochemistry | Q27710548 |
| P1476 | title | DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA | |
| P478 | volume | 15 |
| Q68242691 | A new action for topoisomerase inhibitors |
| Q35594640 | ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells |
| Q36122168 | Aggregation of DNA by analogs of spermidine; enzymatic and structural studies |
| Q68259271 | An ATP-independent catenating enzyme from the kinetoplast hemoflagellate Leishmania donovani |
| Q74261278 | Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35 |
| Q40516307 | Archaebacterial reverse gyrase cleavage-site specificity is similar to that of eubacterial DNA topoisomerases I. |
| Q28570763 | Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription |
| Q36683177 | Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection |
| Q38321795 | Biochemical characteristics and physiological significance of major DNA topoisomerases |
| Q36466122 | Biochemical pharmacology of anthracenediones and anthrapyrazoles |
| Q24627367 | Bioflavonoids as poisons of human topoisomerase II alpha and II beta |
| Q28203339 | Camptothecins: a review of their chemotherapeutic potential |
| Q72257322 | Can nuclear medicine predict response to chemotherapy? |
| Q47235346 | Characterisation of size variants of type I DNA topoisomerase isolated from calf thymus |
| Q34336896 | Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. |
| Q40641040 | Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo |
| Q33340161 | Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer |
| Q36424076 | Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. |
| Q41786070 | DNA gyrase complex with DNA: determinants for site-specific DNA breakage |
| Q34469617 | DNA loop domains in mammalian spermatozoa |
| Q36424250 | DNA topoisomerase I is essential in Drosophila melanogaster |
| Q40818137 | DNA topoisomerase II activity in nonreplicating, transcriptionally inactive, chicken late spermatids |
| Q44938623 | DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26. |
| Q36903197 | DNA topoisomerase II, genotoxicity, and cancer |
| Q41315281 | DNA topoisomerase inhibitors as antifungal agents. |
| Q36758354 | DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs |
| Q67912294 | DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives |
| Q78106623 | Disassembly of genome of higher eukaryotes: pulsed-field gel electrophoretic study of initial stages of chromatin and DNA degradation in rat liver and thymus nuclei by VM-26 and selected proteases |
| Q37576691 | Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome |
| Q40391028 | Effects of the antitumor drug VP16 (etoposide) on the archaebacterial Halobacterium GRB 1.7 kb plasmid in vivo |
| Q40079868 | Enzymology of DNA in Replication in Prokaryote |
| Q33931274 | Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. |
| Q67486552 | Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice |
| Q73726643 | Expression of DNA topoisomerase IIalpha in thyroid neoplasia |
| Q33642912 | Functional expression of a Drosophila gene in yeast: genetic complementation of DNA topoisomerase II |
| Q44872058 | Genetic recombination of homologous plasmids catalysed by cell-free extracts of topo-isomerase mutant strains of Saccharomyces cerevisiae |
| Q72538851 | Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features |
| Q37876263 | In vitro assays used to measure the activity of topoisomerases |
| Q41430324 | Inhibition of DNA synthesis by aphidicolin induces supercoiling in simian virus 40 replicative intermediates |
| Q35561732 | Inhibition of HeLa cell DNA topoisomerase I by ATP and phosphate |
| Q33931676 | Inhibition of calf thymus type II DNA topoisomerase by poly(ADP-ribosylation) |
| Q41050547 | Inhibition of human topoisomerase II by anti-neoplastic benzazolo[3,2-alpha]quinolinium chlorides |
| Q35952935 | Interaction of topoisomerase 1 with the transcribed region of the Drosophila HSP 70 heat shock gene |
| Q35607477 | Isolation and characterization of the gene encoding Drosophila DNA topoisomerase II. |
| Q36213345 | Localization of topoisomerase II in mitotic chromosomes |
| Q36251195 | Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide |
| Q38349989 | Mechanism of inhibition of mammalian DNA topoisomerase I by heparin |
| Q54329609 | Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA. |
| Q70142905 | Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells |
| Q41521938 | Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents |
| Q36892208 | Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells |
| Q37394750 | Replication forks are underrepresented in chromosomal DNA of Xenopus laevis embryos |
| Q36546741 | Resistance to inhibitors of DNA topoisomerases |
| Q37394291 | Role for topoisomerases in the release of DNA into the detergent-soluble fraction of eukaryotic cells |
| Q67699569 | Role of polyamine in the regulation of RNA synthesis in uterine nucleoli |
| Q34595603 | Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro |
| Q28302945 | Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I |
| Q39581388 | Structural aspects of antineoplastic agents--a new approach. |
| Q43733839 | Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2':6',2"-, 2,2':6',3"- and 2,2':6',4"-terpyridine derivatives |
| Q67913548 | The effects of inhibitors of topoisomerase II and quinacrine on ultraviolet-light-induced DNA incision in normal and xeroderma pigmentosum fibroblasts |
| Q41341276 | The epsilon subunit of DNA polymerase III Is involved in the nalidixic acid-induced SOS response in Escherichia coli |
| Q68348279 | The nuclear scaffold exhibits DNA-binding sites selective for supercoiled DNA |
| Q54433856 | The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). |
| Q35616800 | Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase |
| Q40534060 | Topoisomerase I in multiple drug resistance |
| Q40028536 | Topoisomerase I inhibitors and drug resistance |
| Q42002540 | Topoisomerase I is the predominant nuclear protein from avian erythrocytes that can be covalently linked to DNA. |
| Q40535267 | Topoisomerase II in multiple drug resistance |
| Q34684254 | Topoisomerase II is a structural component of mitotic chromosome scaffolds. |
| Q36216632 | Topoisomerase II: A specific marker for cell proliferation |
| Q40499871 | Topoisomerase inhibitors. A review of their therapeutic potential in cancer |
| Q33894566 | Topostin, a novel inhibitor of mammalian DNA topoisomerase I from Flexibacter topostinus sp. nov. II. Purification and some properties of topostin |
| Q35354154 | Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents |
Search more.